Double Prodrugs
"Double Prodrug" is a prodrug derivative that contains two successive metabolically labile promoiety groups, requiring sequential enzymatic or chemical transformations to release the active parent drug, thereby enabling enhanced targeted delivery or improved pharmacokinetic properties compared to single prodrug forms.
56
Publications
1.9K
Citations
276
Authors
91
Institutions
Publications per year
2017–2026
17
Variants
Double Prodrug
Parents
56
Ludovic Peauger, Rabah Azzouz, Vincent Gembus et al. · Journal of Medicinal Chemistry · 2017 · 93 citations · Full text
1–5 of 56
276
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 276
91

Centre National de la Recherche Scientifique
Paris, France
3 h-index
13 publications
648 citations
Panjab University
Chandigarh, India
3 h-index
8 publications
216 citations

Southeast University
Nanjing, China
3 h-index
23 publications
685 citations

University of Southern Denmark
Odense, Denmark
3 h-index
10 publications
296 citations
Inserm
Paris, France
2 h-index
5 publications
162 citations
Bharati Vidyapeeth Deemed University
Pune, India
2 h-index
8 publications
110 citations
Enzon Pharmaceuticals (United States)
Piscataway, United States
2 h-index
14 publications
1.5K citations

Trinity College Dublin
Dublin, Ireland
2 h-index
10 publications
165 citations
1–8 of 91
7 publications · 423 citations
7
h-index
4 publications · 73 citations
4
h-index
4 publications · 99 citations
4
h-index
3 publications · 70 citations
3
h-index
2 publications · 59 citations
2
h-index
1–5